← Issue №19/ week of Nov 8, 2026/IBD

Work disability in patients with newly diagnosed inflammatory bowel disease: Results from the population-based IBSEN III cohort.

From GI Signals issue №19: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

IBD prospective cohort · n=1,234 · Nov 4, 2026 · Inflamm Bowel Dis · IF 4.5

Work disability in patients with newly diagnosed inflammatory bowel disease: Results from the population-based IBSEN III cohort.

New evidenceepidemiologyCrohn's diseaseulcerative colitishealth services
Clinical takeawayAsk about work early in newly diagnosed IBD, especially Crohn's disease at ages 30 to 39; lower self-efficacy and quality of life, not disease activity, were associated with work disability, a possible target for interventions.
What it foundAt 1 year, UC and CD patients had increased risk of AAP compared to the background population (UC RR 1.6, CD RR 3.6), but DP risk was comparable.
ContextConfirms and quantifies the increased risk of WD in IBD patients, particularly AAP, and identifies modifiable factors (self-efficacy, quality of life) associated with WD.
No standard claimed for this paper

Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.

Lund C … Høivik ML · Inflammatory Bowel Diseases · IF 4.5 · PubMed ↗Permalink
← Read the whole of issue №19 Every paper GI Signals surfaces gets a page like this one. All issues